Gla-Rich Protein Across the Chronic Kidney Disease Spectrum: Association with Vascular Calcification Burden and

Antun Lončarić1, Marlena Išek Lončarić2, Diana Balenović1

  • 1Department of Cardiology, General Hospital Dr. Ivo Pedišić Sisak, 44000 Sisak, Croatia.

Insights

Serum Gla-rich protein (GRP) is linked to chronic kidney disease mineral and bone disorder (CKD-MBD) markers like FGF-23 and β-Klotho. Its association with vascular calcification and stiffness in CKD patients was modest.

Area of Science:

  • Nephrology
  • Cardiovascular Biology
  • Biochemistry

Background:

  • Vascular calcification and arterial stiffness are prevalent in chronic kidney disease (CKD).
  • Gla-rich protein (GRP) is a vitamin K-dependent protein involved in mineral metabolism.
  • Limited clinical data exists on GRP's role across various CKD stages.

Purpose of the Study:

  • To investigate the association between serum GRP levels and vascular calcification (VC) burden.
  • To evaluate the relationship between serum GRP and arterial stiffness in individuals across the CKD spectrum.
  • To compare these associations in controls, non-dialysis CKD patients, and hemodialysis patients.

Main Methods:

  • Prospective observational study with 185 adult participants (controls, CKD IIIb-IV, CKD V on hemodialysis).
  • Assessment of abdominal aortic calcification using the Kauppila score and arterial stiffness via pulse wave velocity (PWV).
  • Measurement of serum GRP, FGF-23, and β-Klotho (KLb) using ELISA; statistical analysis included non-parametric comparisons and Bonferroni-corrected Spearman correlations.

Main Results:

  • Serum GRP levels exhibited a non-linear pattern across CKD stages, being lowest in CKD IIIb-IV (p < 0.001).
  • Pulse wave velocity (PWV) and Kauppila scores increased progressively with CKD stage (p < 0.001).
  • Serum GRP strongly correlated with KLb (ρ = 0.720) and FGF-23 (ρ = 0.625) but not directly with PWV or Kauppila score. Multivariable analysis showed modest associations between GRP, PWV, and Kauppila score.

Conclusions:

  • Serum GRP is more strongly associated with CKD-MBD biochemical markers (KLb, FGF-23) than with vascular phenotypes in the CKD spectrum.
  • The associations of GRP with vascular calcification burden and arterial stiffness are modest.
  • GRP may serve as a marker for the CKD-MBD biochemical profile rather than a direct surrogate for vascular disease in CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...